Royalties
- Date:
- 2004-2016
- Reference:
- SA/KET/A/6
- Part of:
- The Kennedy Trust for Rheumatology Research
- Archives and manuscripts
About this work
Description
Correspondence between lawyers and Kennedy Trust/Kennedy Institute staff relating to licensing agreement with Centocor and ongoing royalties from anti-TNF, 2004-2016; patent portfolio report and technology transfer support papers between trust and ISIS Innovation, 2012-2014; royalties forecasting reports on Remicade, Simponi, Humira prepared by LEK, 2012; royalty compliance report prepared by Invotex, 2013; Remicade royalty review prepared by KPMG, 2010-2011.
Publication/Creation
2004-2016
Physical description
1 file (in 4 parts)
Terms of use
This item is closed and cannot be accessed. Please see our Access Policy for more details. Closed until 1 January 2037.
Where to find it
Location Status Access Closed storesClosed Can't be requested